Searched for
LUKE MIELS
$10. 6 billion deal: GSK to buy US cancer specialist Nuvalent- Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapse
- GSK to buy RAPT Therapeutics in $2.2 billion deal for promising food allergy therapy
- Diageo considers external candidates for CEO role, including outgoing GSK boss: ReportsDiageo is reportedly considering external candidates, including former GSK CEO Emma Walmsley, for its chief executive position. This comes ...08 Nov, 2025, 12.25 PM IST
- US stocks tick higher as investors look past hawkish talk, await shutdown clarityU.S. stocks rose Monday, recovering recent losses, despite looming government shutdown fears and new tariffs. Electronic Arts jumped on a $...29 Sep, 2025, 07.27 PM IST
- U.S. stock futures rise today as Dow Jones, S&P 500 and Nasdaq rally ahead of jobs data with Nvidia, Oracle, Intel among top stocks to watchU.S. stock market futures rose Monday morning as investors aimed to bounce back from last week’s losses. Futures tied to the Dow Jones, S&P...29 Sep, 2025, 05.03 PM IST
- European shares gain on healthcare, technology boostEuropean shares inched up on Monday as healthcare and technology shares rose, while investors focused on a possible U.S. government shutdow...29 Sep, 2025, 01.06 PM IST
- GSK to buy US biotech firm IDRx for up to $1.15 billionBritish drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion paymen...13 Jan, 2025, 01.28 PM IST
- US FDA approves first RSV vaccine from GSKThe approval makes GSK, which has been neck-and-neck with Pfizer in RSV vaccine development, the first company to tap into a multi-billion-...03 May, 2023, 11.06 PM IST
- GSK to buy Canada's Bellus Health for $2 blnThe acquisition gives GSK access to camlipixant, which is in late-stage development for the first-line treatment of adult patients with ref...18 Apr, 2023, 12.28 PM IST
- GSK to boost spending power of pharma business post break-upGlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day. GSK's s...21 Jun, 2021, 05.04 PM IST
Load More
